ClinicalTrials.govpublic full text
Cilengitide in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (SCCHN)
squamous cell cancer, randomized treatment, open-label, controlled, recurrent, metastatic, scchn, suitable, for local therapy, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 869612
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.